What is the management approach for CRHM (Chronic Rhinitis with Hypersensitivity and Motor) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Approach for CRHM (Chronic Rhinitis with Hypersensitivity and Motor) Syndrome

The management of CRHM syndrome should focus on identifying underlying allergies and treating with intranasal corticosteroids, saline irrigation, and targeted therapy for specific triggers, rather than following a one-size-fits-all approach. 1

Diagnostic Evaluation

  • Confirm diagnosis with objective documentation of sinonasal inflammation using anterior rhinoscopy, nasal endoscopy, or computed tomography (CT) 1
  • Evaluate for underlying allergies through skin prick testing (preferred method) or blood tests for specific IgE, particularly for perennial allergens such as dust mites, cockroaches, pet dander, and fungi 1
  • Consider CT as the preferred imaging technique when radiographic imaging is needed 1
  • Assess for comorbid conditions that may modify management, including asthma, immunodeficiency, and ciliary dyskinesia 1

First-Line Treatment

  • Intranasal corticosteroids are a cornerstone therapy for symptom relief 1
  • Saline nasal irrigation helps remove irritants, reduce congestion, and improve medication delivery 1
  • For patients with confirmed allergic components, consider adding antihistamines (particularly intranasal formulations like azelastine) 2, 3
  • Anticholinergic nasal sprays (ipratropium) are particularly effective for controlling rhinorrhea symptoms but have minimal effect on congestion 2, 4

Treatment Based on Severity

For Mild Symptoms:

  • Intranasal corticosteroids and saline lavage as initial management 1
  • Monitor response for 3 months 1
  • If symptoms improve, continue therapy with follow-up every 6 months 1

For Moderate to Severe Symptoms:

  • Intranasal corticosteroids (consider higher potency or delivery as drops rather than spray) 1
  • Saline nasal lavage 1
  • Consider short course (1 month) of oral corticosteroids, particularly if nasal polyps are present 1
  • Evaluate for specific triggers and implement avoidance strategies 2

Management of Refractory Cases

  • For patients not responding to initial therapy after 3 months, consider:

    • Culture-directed antibiotic therapy if purulent discharge is present 1
    • Long-term macrolide therapy for immunomodulatory effects 1
    • CT evaluation to assess for structural abnormalities 1
    • Referral for surgical evaluation 1
  • Surgical options should be considered when:

    • Medical management fails after appropriate trials 1
    • Disease is advanced with polyps, osteitis, bony erosion, or fungal involvement 1
    • Surgery should include full exposure of the sinus cavity and removal of diseased tissue, not just balloon or manual ostial dilation 1

Special Considerations

  • Avoid antifungal therapy (topical or systemic) as it is not recommended for CRS management 1

  • For patients with nasal hyperreactivity to non-allergic triggers (vasomotor component):

    • Identify and avoid specific triggers (perfumes, smoke, temperature changes) 2, 3
    • Consider intranasal anticholinergics for predominant rhinorrhea 2, 4
  • Immunologic testing should be considered in patients with:

    • Recurrent or persistent purulent infections 1
    • Failed aggressive management 1
    • Testing may include quantitative immunoglobulin assays (IgG, IgA, IgM) and specific antibody responses to vaccines 1

Common Pitfalls to Avoid

  • Failing to confirm diagnosis with objective evidence of inflammation 1
  • Prescribing antibiotics without evidence of bacterial infection 1
  • Overlooking allergic components that could be effectively managed 1
  • Delaying allergy evaluation until after surgical intervention 1
  • Implementing a rigid "one-size-fits-all" treatment regimen rather than tailoring therapy to the specific subtype and severity of disease 1
  • Relying on mucus color alone to determine need for antibiotics 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Traitement de la Rhinite Vasomotrice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nonallergic Rhinopathy: A Comprehensive Review of Classification, Diagnosis, and Treatment.

The journal of allergy and clinical immunology. In practice, 2024

Research

Management of rhinitis: allergic and non-allergic.

Allergy, asthma & immunology research, 2011

Guideline

Guidelines for Managing Rhinosinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.